We are live on ! Find out more
LPCN icon

Lipocine
LPCN

38 hedge funds and large institutions have $72.4M invested in Lipocine in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

950% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 2

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

144% more capital invested

Capital invested by funds: $29.7M → $72.4M (+$42.7M)

100% more funds holding

Funds holding: 19 → 38 (+19)

Holders
38
Holders Change
+19
Holders Change %
+100%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
21
Increased
11
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Invesco
Invesco
Georgia
+$7.85M
2
AC
Armistice Capital
New York
+$6.21M
3
SM
Sabby Management
Florida
+$5.29M
4
VM
VHCP Management
New York
+$4.38M
5
KCM
Kingdon Capital Management
New York
+$2.19M

Top Sellers

1
BBA
Baker Bros. Advisors
New York
-$3.38M
2
VAM
Visium Asset Management
New York
-$511K
3
JGC
J. Goldman & Co
New York
-$109K
4
VKH
Virtu KCG Holdings
New York
-$97K
5
Goldman Sachs
Goldman Sachs
New York
-$5.34K
Name Holding Trade Value Shares
Change 		Change in
Stake
VM
1
VHCP Management
New York
$10.9M +$4.38M +35,294 +90%
VAM
2
Visium Asset Management
New York
$9.75M -$511K -4,117 -6%
Invesco
3
Invesco
Georgia
$9.22M +$7.85M +63,235 New
AC
4
Armistice Capital
New York
$7.29M +$6.21M +50,000 New
SM
5
Sabby Management
Florida
$6.22M +$5.29M +42,647 New
CAM
6
Cormorant Asset Management
Massachusetts
$5.72M – – –
LOAMU
7
Lombard Odier Asset Management (USA)
New York
$4.43M +$851K +6,859 +29%
KCM
8
Kingdon Capital Management
New York
$2.57M +$2.19M +17,647 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$2.54M +$1.37M +11,071 +175%
RA
10
Royce & Associates
New York
$2.29M +$548K +4,412 +39%
RI
11
RTW Investments
New York
$1.8M – – –
Renaissance Technologies
12
Renaissance Technologies
New York
$1.58M +$1.16M +9,356 +641%
Ameriprise
13
Ameriprise
Minnesota
$1.08M +$334K +2,694 +57%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$730K +$206K +1,663 +50%
DCM
15
DAFNA Capital Management
California
$729K +$621K +5,000 New
Bank of America
16
Bank of America
North Carolina
$713K +$607K +4,889 New
JGC
17
J. Goldman & Co
New York
$643K -$109K -882 -17%
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$568K +$483K +3,892 New
Millennium Management
19
Millennium Management
New York
$456K +$388K +3,130 New
ISL
20
Ingalls & Snyder LLC
New York
$418K +$37.4K +301 +12%
Deutsche Bank
21
Deutsche Bank
Germany
$385K +$328K +2,646 New
BFA
22
BlackRock Fund Advisors
California
$352K +$89.6K +722 +43%
JP Morgan Chase
23
JP Morgan Chase
New York
$301K +$256K +2,065 New
PAWC
24
P.A.W. Capital
Connecticut
$300K +$256K +2,059 New
EDRH
25
Edmond de Rothschild Holding
Switzerland
$270K +$230K +1,851 New
1
2

LPCN Hedge Fund Activity: Q2 2015 in Review

38 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q2 2015, worth a combined $72.4M — up 144% from $29.7M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new LPCN positions and 2 closed out — a net gain of 19 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $7.85M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $3.38M sold.

  • 38 institutional investors held Lipocine (LPCN) as of Q2 2015, up from 19 in Q1 2015.
  • Funds reported $72.4M of Lipocine stock for Q2 2015, up 144% quarter-over-quarter.
  • 21 funds opened new Lipocine positions in Q2 2015 and 2 closed out, a net change of +19 holders.
  • The largest Lipocine buyer in Q2 2015 was Invesco, an estimated $7.85M added.
  • The largest Lipocine seller in Q2 2015 was Baker Bros. Advisors, an estimated $3.38M sold.

Based on aggregated 13F filings for Q2 2015.